| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| R&D Expense | $341K | — |
| SG&A Expense | $93K | +1764.1% |
| Operating Income | -$6.5M | -1990.8% |
| Net Income | -$6.5M | -1990.8% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Inventory | $1K | — |
| Current Assets | $128K | +901.8% |
| Total Assets | $12.1M | — |
| Current Liabilities | $1.2M | +198.6% |
| Total Liabilities | $1.2M | +198.6% |
| Stockholders' Equity | $10.9M | +2903.6% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $44K | +188.7% |
| Financing Cash Flow | -$10K | -119.3% |